Joseph P. Lucia & Associates’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$207K Buy
8,608
+7
+0.1% +$183 0.06% 180
2026
Q1
$242K Sell
8,601
-129
-1% -$3.43K 0.09% 152
2025
Q4
$217K Buy
8,730
+88
+1% +$2.22K 0.08% 151
2025
Q3
$220K Sell
8,642
-1,642
-16% -$40.5K 0.08% 146
2025
Q2
$249K Sell
10,284
-10,044
-49% -$234K 0.1% 129
2025
Q1
$515K Sell
20,328
-1,713
-8% -$44.8K 0.24% 83
2024
Q4
$585K Sell
22,041
-9,094
-29% -$247K 0.26% 77
2024
Q3
$901K Buy
31,135
+2,798
+10% +$81.6K 0.42% 65
2024
Q2
$793K Buy
28,337
+19,134
+208% +$527K 0.41% 64
2024
Q1
$255K Buy
+9,203
New +$255K 0.14% 102
2022
Q3
Sell
-966
Closed -$51K 354
2022
Q2
$51K Sell
966
-250
-21% -$12.7K 0.04% 178
2022
Q1
$63K Buy
+1,216
New +$63.1K 0.04% 179
2021
Q4
Sell
-1,216
Closed -$52K 431
2021
Q3
$52K Hold
1,216
0.03% 213
2021
Q2
$48K Hold
1,216
0.03% 224
2021
Q1
$44K Sell
1,216
-76
-6% -$2.7K 0.02% 212
2020
Q4
$48K Buy
+1,292
New +$47.4K 0.03% 188
2020
Q3
Sell
-522
Closed -$16K 354
2020
Q2
$16K Sell
522
-316
-38% -$10.7K 0.01% 263
2020
Q1
$26K Buy
838
+149
+22% +$5.08K 0.03% 210
2019
Q4
$26K Sell
689
-154
-18% -$5.49K 0.02% 221
2019
Q3
$29K Sell
843
-264
-24% -$9.6K 0.03% 216
2019
Q2
$46K Sell
1,107
-42,316
-97% -$1.68M 0.05% 179
2019
Q1
$955 Buy
+43,423
New +$1.74M 0.07% 125

Other funds holding PFE

Joseph P. Lucia & Associates's PFE Position: Q2 2026 in Review

Joseph P. Lucia & Associates increased its Pfizer (PFE) stake by 0.08% in Q2 2026, buying an estimated $183 and bringing the position to 8,608 shares worth $207K. The position accounts for 0.06% of the portfolio, ranked #180.

Joseph P. Lucia & Associates first reported a position in PFE in Q1 2019 and has held it in 22 quarters since. The position peaked at $901K in Q3 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Joseph P. Lucia & Associates held 8,608 shares of Pfizer worth $207K as of Q2 2026.
  • Joseph P. Lucia & Associates bought 7 Pfizer shares in Q2 2026, an estimated $183.
  • Pfizer made up 0.06% of Joseph P. Lucia & Associates's portfolio in Q2 2026, its #180 holding.
  • Joseph P. Lucia & Associates first reported a position in Pfizer in Q1 2019 and has held it in 22 quarters since.
  • Joseph P. Lucia & Associates's Pfizer position peaked at $901K in Q3 2024.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Joseph P. Lucia & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.